Schluessel, Sabine
Mueller, Benedikt
Tausendfreund, Olivia
Rippl, Michaela
Deissler, Linda
Martini, Sebastian
Schmidmaier, Ralf
Stoecklein, Sophia
Ingrisch, Michael
Blaschke, Sabine
Brandhorst, Gunnar
Spieth, Peter
Lehnert, Kristin
Heuschmann, Peter
de Miranda, Susana M. Nunes
Drey, Michael
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 18 March 2025
Accepted: 6 May 2025
First Online: 16 May 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. For the NAPKON SUEP, a primary ethics vote was obtained at the Ethics Committee of the Department of Medicine at Goethe University Frankfurt (local ethics ID approval 20–924). All further study sites received their local ethics votes at the respective ethics commissions. The NAPKON SUEP is registered at ClinicalTrials.gov (Identifier: NCT04768998). Approval for this study was granted by the Ethics Committee of LMU Munich, Germany (study no. 22–0671).
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.